tosylate

tosylate

 [to´sĭ-lāt]
USAN contraction for p-toluenesulfonate.

to·sy·late

(tō'si-lāt),
USAN-approved contraction for p-toluenesulfonate.

tosylate

/to·sy·late/ (to´sĭ-lāt) USAN contraction for p- toluenesulfonate.

tosylate

USAN contraction for p-toluenesulfonate.
References in periodicals archive ?
3M in collaboration and license revenue, which was primarily related to a portion of the $25M initial license payment received from Maruho pursuant to the exclusive license agreement entered into in September 2016 which granted Maruho the right to develop and commercialize glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis in Japan.
The first finding was the realization of a new synthetic route to glycosyl fluorides by using a dehydrating reagent, 2-fluoro-1-methylpyridinium tosylate (8) (Fig.
Lai, Design, Synthesis, Testing, and Quantitative Structure-Activity Relationship Analysis of Substituted Salicylaldehyde Schiff bases of 1- amino-3-hydroxyguanidine tosylate as New Antiviral Agents Against Coronavirus.
The subject of this procurement is to ensure the continuous partial orders of a medicinal product containing the active substance sorafenib tosylate (Sorafenib Tosilas) for Na Homolce Hospital for the duration of the framework agreement.
an Indian generic drug manufacturer to sell Bayer's patented chemotherapy drug Nexavar (Sorafenib Tosylate, i.
The Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery (ASSURE) study was a Phase 3 study involving 1943 patients with resected RCC (pT1b high-grade to pT4 any grade) at intermediate-high to very high risk.
Multi-walled carbon nanotube-imidazolium tosylate ionic liquid lubricant, Tribol Lett, 50(2): 127-136.
In this paper we present formulation and optimization of hydroxyapatite nanoparticles loaded with sorafenib tosylate based on 23 full factorial design.
Using this provision, the patent controller in March 2012 issued a compulsory licence ( CL) to Natco to produce and market Bayer's patented drug sorafenib tosylate.
Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules involved in tumor growth and progression (everolimus, sorafenib tosylate, sunitinib maleate, temsirolimus).
These stabilizers include tosylate, disulfate tosylate, disulfate ditosylate and 1,4-butane disulfonate (Actimet[R]).